This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Healthy Volunteers
and you are
between 18 and 45
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The purpose of this study is to evaluate the potential effect of bardoxolone methyl on the pharmacokinetics of digoxin and rosuvastatin and to assess the safety of the concomitant administration of bardoxolone methyl with digoxin or rosuvastatin.

Provided treatments

  • Drug: Digoxin
  • Drug: Rosuvastatin
Tris trial is registered with FDA with number: NCT01598363. The sponsor of the trial is Reata Pharmaceuticals, Inc. and it is looking for 32 volunteers for the current phase.
Official trial title: